Blue Shield of California has announced three tobacco-cessation online providers to its popular Wellvolution platform, the largest Digital Therapeutics (DTX or PDT), and community network in the healthcare industry. With 49 million Americans using tobacco of some kind, the increased risk for multiple diseases has largely driven Blue Shield to add three new clinically proven health solutions for the 23,000+ members enrolled in Wellvolution.
Delaware-based health system ChristianaCare is expanding its innovative work to transform care through data and technology by adding Pear’s prescription digital therapeutics (PDTs or DTx) to treat substance use disorder and opioid use disorder. ChristianaCare will provide patients access to Boston-based Pear Therapeutics Inc.’s reSET and reSET-O PDTs through Project Recovery, ChristianaCare’s outpatient program for people with substance-use disorders.
Opear MD, a digital health membership-based app for on-demand house calls and telemedicine appointments, has announced two initiatives to increase healthcare accessibility and affordability during COVID-19.
